Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 1/10/2021 → 31/12/2022 |
Collaborative partners
- King's College London (lead)
- Takeda Pharmaceuticals International
- University of Sheffield
Funding
- Takeda Pharmaceutical Company Limited: £9,870.70
Targeting TDP-43 autoregulation for therapeutic benefit in ALS-FTD
- White, Matthew (Primary Investigator)
- Sreedharan, Jemeen (Co-Investigator)
Project: Research